ALSO NOTED: Canada sees low takeup for free cervical cancer shots; NYU advances brain cancer vaccine; and much more...
Iomai vax patch guards against traveler's diarrhea
Iomai is touting the results of a mid-stage study of its vaccine patch for traveler's diarrhea. Iomai researchers say that the patch delivered a robust immune response among the 160 volunteers in the
Booming vaccine biz swells Sanofi's revenue
A sign of the times? When Sanofi-Aventis presented its 2007 results earlier this week, it trumpeted the 14.5 percent sales growth in its vaccines group. That's more than double its pharma growth--and
Sanofi licenses technology for new TB vaccine
Sanofi Pasteur has struck a licensing deal with the Statens Serum Institut of Denmark covering the use of its technology for a new tuberculosis vaccine. The pact includes SSI's Intercell IC31
Vaccines miss their mark in seasonal flu campaign
Each year vaccine makers create a cocktail of antigens designed to stand guard against the various versions of the flu making the rounds in winter. But this year the CDC concludes that most of the
SPOTLIGHT: Sanofi files new vaccine tech
Sanofi Pasteur has submitted the first vaccine delivered by an intradermal microinjection system for European approval. The vaccine is delivered to the dermal layer, triggering a response in
ALSO NOTED: Acambis inks smallpox contract; Yellow fever outbreak; Researchers see promise for stomach flu vaccines; and much m
Researchers five years from prostate cancer vax
Australia's Mater Medical Research Institute is in Phase I clinical trials with a prostate cancer vaccine that it believes could be approved in five years. The researchers are using technology to
France to probe GSK, Sanofi vaccination campaign
French authorities are investigating GlaxoSmithKline and Sanofi Pasteur over an anti-hepatitis B vaccination campaign in the 1990s. At issue is whether the companies fully disclosed the shot's
Cold feet at FDA over Cervarix approval?
Chimp virus plays key role in malaria vaccine
A new blend of a genetically modified chimp adenovirus and a malaria gene is proving promising as a potential vaccine against malaria. The adenovirus is used to spur an immune response against
SPOTLIGHT: Distrust can overcome data
Despite fresh evidence that the MMR vaccine jab does not raise the risk of autism, observers say that the deep level of public distrust for the drug industry will keep this kernel of misinformation
ALSO NOTED: University provides free HPV shots; Intercell reports successful mid-stage hep C study; Tattooing effective in deli
Researchers develop needle-free vaccine delivery
South Korean researchers have successfully tested a new approach to delivering vaccines, applying it under the tongue rather than through a needle. In a mouse study, the under-the-tongue approach
Study: Thoughts can impact vaccine efficacy
A patient's thoughts and feelings play a big role in determining just how effective their annual flu shot can be, says a new study from the University of Wisconsin. In the study, researchers divided
Scientists tackle vaccine for nicotine addiction
An in-development vaccine that weans addicts from their substance of choice has shown the most promise against cocaine addiction so far, but its developers are testing it against other substances
FDA warns Novartis over contaminated vaccines
The FDA has warned Novartis Vaccines and Diagnostics of the "significant deviations" found at its manufacturing plant in Marburg, Germany, accusing the pharma giant of producing contaminated vaccines
SPOTLIGHT: Study tracks mercury in vaccines
A new study indicates that the mercury in vaccines disappears quickly from the blood. Investigators in Argentina were exploring the controversial claim that the mercury in vaccines was responsible
ALSO NOTED: ABC urged to cancel vaccine-related show; New studies on H5N1 vaccines; and much more...
Vaccine Market The American Academy of Pediatrics wants ABC to cancel "Eli Stone," a new show, saying it gives its audience the false idea that vaccines cause autism. In the first episode, a mother
Adults steering clear of a new vaccines
American adults are largely ignoring a slate of important new vaccines that can prevent serious illness, according to a new survey from the National Foundation for Infectious Diseases. Only about
THE LIBRARY: WEBINAR
Improve the Inclusion & Exclusion Criteria for Your Next Clinical Trial
In this webinar, Dr. Jack Modell will provide suggestions and advice on formulating inclusion and exclusion criteria to enhance the quality of subject selection, minimize protocol violations, and avoid protocol amendments. Register Today!
Latest Commentary
Combating HIV: The future of therapeutic vaccines
10 promising therapeutic vaccines in 2012
The 20 top-selling vaccines in H1 2012
GeoVax: Meeting the HIV vaccine challenge
Wishing you a happy HIV Vaccine Awareness Day
more
EVENTS
- Drug Development Boot Camp - November 19-20, 2014, Boston, MANovember 19-20, 2014 — Boston, MA — Hosted by Harvard University OTD and Speid & Associates, Inc.